Research Progress on Natural Triterpenoid Saponins in the Chemoprevention and Chemotherapy of Cancer

Enzymes

Volumn 36, Issue , 2014, Pages 95-130

  Du, Jun Rong ^a   Long, Fang Yi ^a   Chen, Chu ^b  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Traditional Chinese Medicine Sciences   (China)

Author keywords

Anticancer activities; Clinical trials; Mechanisms; Structure activity relationship; Triterpenoid saponins

Indexed keywords

EID: 84919413962     PISSN: 18746047     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-802215-3.00006-9     Document Type: Chapter

References (116)

1. Augustin J.M., et al. Molecular activities, biosynthesis and evolution of triterpenoid saponins. Phytochemistry 2011, 72(6):435-457.
2. Ali R., et al. New anticancer agents: Recent developments in tumor therapy. Anticancer Res. 2012, 32(7):2999-3005.
3. Man S., et al. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 2010, 81(7):703-714.
4. Sparg S.G., Light M.E., van Staden J. Biological activities and distribution of plant saponins. J. Ethnopharmacol. 2004, 94(2-3):219-243.
5. Qi L.W., Wang C.Z., Yuan C.S. American ginseng: Potential structure-function relationship in cancer chemoprevention. Biochem. Pharmacol. 2010, 80(7):947-954.
6. Haridas V., et al. Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(10):5821-5826.
7. Xu Z.X., et al. Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts. PLoS One 2009, 4(12):e8532.
8. Xu Z.X., et al. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ. 2007, 14(11):1948-1957.
9. Gaikwad A., et al. Triterpenoid electrophiles (Avicins) suppress heat shock protein-7 and X-linked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: Implications for proapoptotic activity. Clin. Cancer Res. 2005, 11(5):1953-1962.
10. Haridas V., et al. Avicin D: A protein reactive plant isoprenoid dephosphorylates Stat 3 by regulating both kinase and phosphatase activities. PLoS One 2009, 4(5):e5578.
11. Fukumura M., et al. Achyranthoside H methyl ester, a novel oleanolic acid saponin derivative from Achyranthes fauriei roots, induces apoptosis in human breast cancer MCF-7 and MDA-MB-453 cells via a caspase activation pathway. J. Nat. Med. 2009, 63(2):181-188.
12. Harikumar K.B., et al. Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-κB signaling pathway. Mol. Pharmacol. 2010, 77(5):818-827.
13. Shen D.Y., et al. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway. Phytother. Res. 2011, 25(10):1519-1526.
14. Ming Z.J., et al. Synergistic effects of β-aescin and 5-fluorouracil in human hepatocellular carcinoma SMMC-7721 cells. Phytomedicine 2010, 17(8-9):575-580.
15. Ji D.B., et al. β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells. Mol. Carcinog. 2011, 50(12):945-960.
16. Tan S.M., et al. Identification of β-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated Kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. J. Pharmacol. Exp. Ther. 2010, 334(1):285-293.
17. waf1/cip1 in colon cancer cells. Mol. Cancer Ther. 2006, 5(6):1459-1466.
18. Patlolla J.M., et al. β-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prev. Res. (Phila) 2013, 6(10):1140-1149.
19. Shi J.M., et al. Saxifragifolin D induces the interplay between apoptosis and autophagy in breast cancer cells through ROS-dependent endoplasmic reticulum stress. Biochem. Pharmacol. 2013, 85(7):913-926.
20. Xue G., et al. Raddeanin A induces human gastric cancer cells apoptosis and inhibits their invasion in vitro. Biochem. Biophys. Res. Commun. 2013, 439(2):196-202.
21. Lou L., et al. Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine 2012, 19(7):603-608.
22. Auyeung K.K., et al. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J. Ethnopharmacol. 2012, 141(2):635-641.
23. Huang C., et al. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J. Pharm. Pharmacol. 2012, 64(12):1741-1750.
24. Qi H., et al. Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2. Int. J. Oncol. 2010, 36(3):725-735.
25. Weng X.Y., Ma R.D., Yu L.J. Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I. Ai Zheng 2003, 22(8):806-811.
26. Yin Y., et al. NF-κB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G2/M cell cycle arrest. Food Chem. Toxicol. 2011, 49(12):3046-3054.
27. Huang P., et al. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway. Int. J. Mol. Med. 2011, 28(4):579-587.
28. Wang Y., et al. Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells. Biol. Pharm. Bull. 2011, 34(6):831-838.
29. Zhang Y., Xu X., He P. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells. Mol. Med. Rep. 2011, 4(1):25-29.
30. 2+ and caspase-dependent signaling pathways. Int. J. Oncol. 2012, 40(2):535-543.
31. Kim B.M., Hong S.H. Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines. Apoptosis 2011, 16(2):184-197.
32. Wong V.K., et al. Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis. 2013, 4:e720.
33. Lu X.L., et al. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: Involvement of CCAAT/enhancer binding protein β and cyclooxygenase-2. Mol. Med. Rep. 2012, 5(3):637-644.
34. Jia X., et al. Effects of saikosaponin-D on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma. J. Tradit. Chin. Med. 2012, 32(3):415-422.
35. Guo L.Y., et al. Cimiside E arrests cell cycle and induces cell apoptosis in gastric cancer cells. Arch. Pharm. Res. 2009, 32(10):1385-1392.
36. Mallick S., et al. Corchorusin-D directed apoptosis of K562 cells occurs through activation of mitochondrial and death receptor pathways and suppression of AKT/PKB pathway. Cell. Physiol. Biochem. 2012, 30(4):915-926.
37. Xu M.Y., et al. Akebia saponin PA induces autophagic and apoptotic cell death in AGS human gastric cancer cells. Food Chem. Toxicol. 2013, 59:703-708.
38. Mo S., et al. Phaseoloideside E, a novel natural triterpenoid saponin identified from Entada phaseoloides, induces apoptosis in EC-109 esophageal cancer cells through reactive oxygen species generation. J. Pharmacol. Sci. 2013, 122(3):163-175.
39. Nhiem N.X., et al. Cytotoxic oleane-type triterpene saponins from Glochidion eriocarpum. Arch. Pharm. Res. 2012, 35(1):19-26.
40. Pei Y., et al. Apoptosis effects on human esophageal cancer cells by soyasaponin Bb and its mechanism. Wei Sheng Yan Jiu 2010, 39(4):444-446.
41. Li M., et al. Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2α by unique interference with its DNA binding and catalytic cycle. Ann. Oncol. 2010, 21(3):597-607.
42. Hwang Y.S., Park K.K., Chung W.Y. Kalopanaxsaponin A inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking. Biol. Pharm. Bull. 2012, 35(3):289-300.
43. Guan F., et al. Apoptosis and membrane permeabilisation induced by macranthoside B on HL-60 cells. Nat. Prod. Res. 2011, 25(4):332-340.
44. Koczurkiewicz P., et al. Triterpene saponosides from Lysimachia ciliate differentially attenuate invasive potential of prostate cancer cells. Chem. Biol. Interact. 2013, 206(1):6-17.
45. Mai T.T., et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012, 321(2):144-153.
46. Choi C.H., Kang G., Min Y.D. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med. 2003, 69(3):235-240.
47. Saw C.L., et al. Pharmacodynamics of ginsenosides: Antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations. Chem. Res. Toxicol. 2012, 25(8):1574-1580.
48. Pokharel Y.R., et al. Increased ubiquitination of multidrug resistance1 by ginsenoside Rd. Nutr. Cancer 2010, 62(2):252-259.
49. Yoon J.H., et al. Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine 2012, 19(3-4):284-292.
50. Cai S., et al. Experimental study on human leukemia cell line K562 senescence induced by ginsenoside Rg1. Zhongguo Zhong Yao Za Zhi 2012, 37(16):2424-2428.
51. Li J., et al. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/Epo human leukemia cell line. Asian Pac. J. Cancer Prev. 2014, 15(6):2453-2459.
52. Kim S.M., et al. Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 2009, 32(5):755-765.
53. Kim S.M., et al. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB. Eur. J. Pharmacol. 2010, 631(1-3):1-9.
54. Kim J.W., et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol. Ther. 2012, 13(7):504-515.
55. Chen Q.J., Zhang M.Z., Wang L.X. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell. Physiol. Biochem. 2010, 26(6):849-858.
56. Liu T.G., et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009, 9:250.
57. Zhang C., et al. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol. Med. Rep. 2012, 5(5):1295-1298.
58. Jiang J.W., et al. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J. Gastroenterol. 2011, 17(31):3605-3613.
59. Kim B.J., et al. Transient receptor potential melastatin 7 channels are involved in ginsenoside Rg3-induced apoptosis in gastric cancer cells. Basic Clin. Pharmacol. Toxicol. 2011, 109(4):233-239.
60. Lee C.K., et al. Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem. Toxicol. 2012, 50(7):2565-2574.
61. Jian J., Hu Z.F., Huang Y. Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1. Ai Zheng 2009, 28(5):461-465.
62. Pan X.Y., et al. Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells. Eur. J. Pharmacol. 2012, 683(1-3):27-34.
63. Wang X., et al. Ginsenoside Rg3 induces apoptosis of human lung squamous cell carcinoma SK-MES-1 cell line. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29(9):1823-1826.
64. He B.C., et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. Int. J. Oncol. 2011, 38(2):437-445.
65. Kim S.W., et al. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem. Pharmacol. 2003, 65(1):75-82.
66. Yang L.Q., et al. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(S)-ginsenoside Rg3 in vivo. Biopharm. Drug Dispos. 2012, 33(8):425-436.
67. Lee J.Y., et al. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol. Cancer Ther. 2013, 12(3):274-285.
68. Yoon J.H., Choi Y.J., Lee S.G. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur. J. Pharmacol. 2012, 679(1-3):24-33.
69. Wu N., et al. Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol. Sin. 2011, 32(3):345-353.
70. An I.S., et al. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells. Oncol. Rep. 2013, 29(2):523-528.
71. Kim M.J., et al. AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2. J. Ginseng Res. 2014, 38(1):16-21.
72. Chung K.S., et al. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression. Carcinogenesis 2013, 34(2):331-340.
73. Kip1-dependent inhibition of cyclin-dependent kinases. Pharm. Res. 2009, 26(10):2280-2288.
74. Park E.K., et al. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt. Br. J. Pharmacol. 2010, 160(5):1212-1223.
75. Cheng C.C., et al. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 2005, 55(6):531-540.
76. Yi J.S., et al. Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption. Biochem. Biophys. Res. Commun. 2009, 385(2):154-159.
77. Jia W.W., et al. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can. J. Physiol. Pharmacol. 2004, 82(7):431-437.
78. Choi S., Oh J.Y., Kim S.J. Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J. Cell. Biochem. 2011, 112(1):330-340.
79. Zhang J., et al. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br. J. Pharmacol. 2012, 165(1):120-134.
80. Park B., et al. Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells. BMC Complement. Altern. Med. 2013, 13:194.
81. Zhang L.H., et al. AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species. Biochim. Biophys. Acta 2013, 1830(8):4148-4159.
82. 3-PPD inhibits breast cancer growth and metastasis through downregulating MDM2. PLoS One 2012, 7(7):e41586.
83. Zhao Q., et al. Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions. J. Zhejiang Univ. Sci. B 2011, 12(7):534-544.
84. Chun J., Ha I.J., Kim Y.S. Antiproliferative and apoptotic activities of triterpenoid saponins from the roots of Platycodon grandiflorum and their structure-activity relationships. Planta Med. 2013, 79(8):639-645.
85. Kim M.O., et al. Platycodin D induces mitotic arrestin vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells. Int. J. Cancer 2008, 122(12):2674-2681.
86. Ye Y., et al. Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines. Environ. Toxicol. Pharmacol. 2013, 36(1):115-124.
87. Qin H., et al. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway. Tumour Biol. 2014, 35(2):1267-1274.
88. Yu J.S., Kim A.K. Platycodin D induces apoptosis in MCF-7 human breast cancer cells. J. Med. Food 2010, 13(2):298-305.
89. Chun J., Kim Y.S. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chem. Biol. Interact. 2013, 205(3):212-221.
90. Arai M., et al. Anti-angiogenic effect of triterpenoidal saponins from Polygala senega. J. Nat. Med. 2011, 65(1):149-156.
91. Hong S.W., et al. SB365, Pulsatillasaponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis 2013, 34(9):2156-2169.
92. Son M.K., et al. SB365, Pulsatillasaponin D suppresses the proliferation of human colon cancer cells and induces apoptosis by modulating the AKT/mTOR signalling pathway. Food Chem. 2013, 136(1):26-33.
93. Guan F., et al. Bigelovii A induces apoptosis of HL-60 human acute promyelocytic leukaemia cells. Mol. Med. Rep. 2013, 7(5):1585-1590.
94. Zhu X., et al. Ziyuglycoside II inhibits the growth of human breast carcinoma MDA-MB-435 cells via cell cycle arrest and induction of apoptosis through the mitochondria dependent pathway. Int. J. Mol. Sci. 2013, 14(9):18041-18055.
95. Zhang T., et al. Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. Autophagy 2012, 8(4):559-576.
96. Ishdorj G., Johnston J.B., Gibson S.B. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis. Mol. Cancer Ther. 2010, 9(12):3302-3314.
97. Xu M.Y., et al. Antitumor activity of Jujuboside B and the underlying mechanism via induction of apoptosis and autophagy. J. Nat. Prod. 2014, 77(2):370-376.
98. Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25(34):4798-4811.
99. Dimberg L.Y., et al. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 2013, 32(11):1341-1350.
100. Gewirtz D.A. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy 2013, 9(9):1263-1265.
101. + cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 2004, 103(8):3175-3184.
102. Klampfer L. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Curr. Cancer Drug Targets 2006, 6(2):107-121.
103. Kim H.J., Hawke N., Baldwin A.S. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 2006, 13(5):738-747.
104. Zhang L., et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(24):9136-9141.
105. Izzotti A., et al. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 2012, 751(2):287-303.
106. Xu K., et al. Cytotoxic activity of Pulsatilla chinensis saponins and their structure-activity relationship. J. Asian Nat. Prod. Res. 2013, 15(6):680-686.
107. Bang S.C., et al. Antitumor activity of Pulsatilla koreana saponins and their structure-activity relationship. Chem. Pharm. Bull. 2005, 53(11):1451-1454.
108. Zhang Z., Li S. Cytotoxic triterpenoid saponins from the fruits of Aesculus pavia L. Phytochemistry 2007, 68(15):2075-2086.
109. Nag S.A., et al. Ginsenosides as anticancer agents: In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front. Pharmacol. 2012, 3:25.
110. Kim J.H., Park C.Y., Lee S.J. Effects of Sun Ginseng on subjective quality of life in cancer patients: A double-blind, placebo-controlled pilot trial. J. Clin. Pharm. Ther. 2006, 31(4):331-334.
111. Cui Y., et al. Association of ginseng use with survival and quality of life among breast cancer patients. Am. J. Epidemiol. 2006, 163(7):645-653.
112. Caso Marasco A., et al. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp. Clin. Res. 1996, 22(6):323-329.
113. Barton D.L., et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: A randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support. Care Cancer 2010, 18(2):179-187.
114. Kamangar F., et al. Ginseng intake and gastric cancer risk in the Shanghai women's health study cohort. Cancer Epidemiol. Biomarkers Prev. 2007, 16(3):629-630.
115. Yun T.K., Choi S.Y. Non-organ specific cancer prevention of ginseng: A prospective study in Korea. Int. J. Epidemiol. 1998, 27(3):359-364.
116. Yun T.K., et al. Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers. J. Med. Food 2010, 13(3):489-494.